BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 17277153)

  • 1. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
    Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH; Stein JM
    J Immunol; 2007 Feb; 178(4):2458-68. PubMed ID: 17277153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
    Daniel C; Sartory NA; Zahn N; Schmidt R; Geisslinger G; Radeke HH; Stein JM
    Mol Immunol; 2007 Jul; 44(13):3305-16. PubMed ID: 17475330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro.
    Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Huang Y
    Int J Mol Med; 2012 Jul; 30(1):211-9. PubMed ID: 22576630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
    Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
    J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
    Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
    Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells.
    Dutra RC; Cola M; Leite DF; Bento AF; Claudino RF; Nascimento AF; Leal PC; Calixto JB
    Br J Pharmacol; 2011 May; 163(2):358-74. PubMed ID: 21244371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720-induced conversion of conventional Foxp3- CD4+ T cells to Foxp3+ regulatory T cells in NOD mice.
    Sun Y; Wang W; Shan B; Di J; Chen L; Ren L; Li W; Li DJ; Lin Y
    Am J Reprod Immunol; 2011 Nov; 66(5):349-62. PubMed ID: 21623989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
    Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis.
    Mizushima T; Ito T; Kishi D; Kai Y; Tamagawa H; Nezu R; Kiyono H; Matsuda H
    Inflamm Bowel Dis; 2004 May; 10(3):182-92. PubMed ID: 15290910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro.
    Zhou PJ; Wang H; Shi GH; Wang XH; Shen ZJ; Xu D
    Clin Exp Immunol; 2009 Jul; 157(1):40-7. PubMed ID: 19659769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators.
    Sehrawat S; Rouse BT
    J Immunol; 2008 Jun; 180(11):7636-47. PubMed ID: 18490766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
    Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
    World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells.
    Liu G; Bi Y; Wang R; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Zhang Z; Chen W; Chu Y; Yang R
    J Immunol; 2014 Apr; 192(7):3068-79. PubMed ID: 24567529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis.
    Bai A; Lu N; Guo Y; Liu Z; Chen J; Peng Z
    J Leukoc Biol; 2009 Oct; 86(4):959-69. PubMed ID: 19477911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo.
    Wolf AM; Eller K; Zeiser R; Dürr C; Gerlach UV; Sixt M; Markut L; Gastl G; Rosenkranz AR; Wolf D
    J Immunol; 2009 Sep; 183(6):3751-60. PubMed ID: 19692647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice.
    Duan L; Chen J; Zhang H; Yang H; Zhu P; Xiong A; Xia Q; Zheng F; Tan Z; Gong F; Fang M
    Mol Med; 2012 Jul; 18(1):753-61. PubMed ID: 22426954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice.
    Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Wang D; Huang Y
    Mol Vis; 2012; 18():624-33. PubMed ID: 22509094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of ROCK2 activity in facilitating mucosal CD4
    Yang W; Zhou G; Yu T; Chen L; Yu L; Guo Y; Cong Y; Liu Z
    J Autoimmun; 2018 May; 89():125-138. PubMed ID: 29269245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.